UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009928
Receipt No. R000011634
Scientific Title ECRIPS: Phase II study of docetaxel, cisplatin and cetuximab (TPE) followed by cetuximab with Concurrent Radiotherapy in Patients with local advanced Squamous cell carcinoma of the Head and Neck (LA-SCCHN).
Date of disclosure of the study information 2013/03/10
Last modified on 2018/10/03 17:09:07

No. Disposal Last modified on Item of update
1 Insert 2013/02/01 15:19:53
2 Update 2013/04/15 16:19:11 UMIN ID1
3 Update 2013/04/16 15:28:19 Public title
Acronym
Acronym
4 Update 2013/04/16 16:48:58 Narrative objectives1
Trial characteristics_1
Developmental phase
5 Update 2013/04/16 21:50:58 Type of intervention
Interventions/Control_1
Key exclusion criteria
Key exclusion criteria
6 Update 2013/04/16 22:01:38 TEL
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Institute
Organization
Organization
Nationality of Funding Organization
Nationality of Funding Organization
Research ethics review
7 Update 2013/04/16 22:31:14 Primary outcomes
Key secondary outcomes
Key secondary outcomes
8 Update 2013/04/16 22:35:08 Control
Key exclusion criteria
9 Update 2013/08/01 14:16:20 UMIN ID2
10 Update 2013/08/02 13:42:07 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
11 Update 2014/01/17 10:44:09 Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
12 Update 2014/01/17 10:58:12 Recruitment status
13 Update 2016/03/01 14:12:07 Recruitment status
14 Update 2016/08/04 09:31:23 Email
Last name of contact person
Last name of contact person
TEL
Name of person sending information
Name of person sending information
TEL
Name of primary sponsor
Organization
15 Update 2016/11/15 09:31:13 Institutions
16 Update 2016/11/15 09:33:43 Last follow-up date
17 Update 2017/08/07 09:56:00 Date trial data considered complete
Date analysis concluded
18 Update 2018/10/03 17:08:52 Public title
19 Update 2018/10/03 17:09:07 Recruitment status


Contact us.